Zelnorm News
Most Popular Zelnorm Story
Novartis plots 2,500 more job cuts
CEO Daniel Vasella (photo) gave us the Read more...
Latest Headlines
- June 1, 2009
- April 3, 2008
- January 18, 2008
- December 13, 2007
- November 29, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
